Sara M. Federico Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Humanized anti-gd2 antibody (hu14.18k322a) with Chemotherapy +/- parental natural killer (nk) cells in children with recurrent/ refractory Neuroblastoma — Parallel 12 Immunotherapy and Early Phase Trials